FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in The Netherlands

Biotech startups in The Netherlands

Updated 16 Nov 2026

Reset
Biotech startups in The Netherlands
One-time CSV
  • 124 funded companies, 72 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~the-netherlands.csv124 rows × 18 columns
CompanyCityLast roundAmountDate
CradleDelftSeries B$73.0M2024-11-26
KynexisNaardenSeries A$112.3M2026-08-19
Vico TherapeuticsLeidenSeries B$12.3M2024-06-24
VectorYAmsterdamSeries A$138.0M2023-11-13
Matisse PharmaceuticalsGeleenSeries A$16.0M2026-09-17
QoriumMaastrichtSeries A$25.5M2025-11-11
OASYS NOWDelftSeed$1.0M2024-11-22
VSPARTICLEDelftSeries A$7.1M2024-08-08

8 rows of the CSV in 5 of its 18 columns.

124
Startups
$1.4B
Total raised
12
Funded in the last 12 months
$274.5M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

16 of 124
16 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Matisse Pharmaceuticals Matisse Pharmaceuticals develops therapies for sepsis and septic shock by targeting cytotoxic histones. Biotech Geleen Series A $16.0M 2026-09-17 $22.0M Brightlands Venture Partners, Chemelot Ventures, Limburg Business Development Fund (LBDF) 11 to 50 2014
Kynexis Kynexis develops precision medicine treatments for cognitive impairment associated with schizophrenia. Biotech Naarden Series A $112.3M 2026-08-19 $173.3M Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures 11 to 50 2023
Pan Cancer T Pan Cancer T develops T-cell receptor therapies for treating solid tumors. Biotech Rotterdam Seed $5.8M 2025-12-08 $16.3M InnovationQuarter, Thuja Capital, Van Herk Ventures +1 1 to 10 2020
Qorium Qorium makes reinvented real leather materials. Biotech Maastricht Series A $25.5M 2025-11-11 $28.6M Sofinnova Partners, Brightlands Venture Partners 11 to 50 2021
CryoCloud CryoCloud provides cloud-based cryo-EM image analysis for protein structure determination. Biotech Utrecht Seed $2.3M 2025-05-06 $2.8M Nina Capital, ROM Utrecht Region, Utrecht Health Seed Fund 1 to 10 2021
Cradle Cradle uses AI prediction algorithms to help biologists design proteins. Artificial intelligence Delft Series B $73.0M 2024-11-26 Index Ventures, IVP, Kindred Capital 11 to 50 2021
OASYS NOW OASYS NOW is a medtech startup that uses AI to improve clinical trial recruitment. Artificial intelligence Delft Seed $1.0M 2024-11-22 Graduate Ventures, ASIF Ventures, TenNine VC 1 to 10 2021
VSPARTICLE VSPARTICLE makes nanoparticle generators for sensors, batteries, catalysis, solar cells, and other uses. Biotech Delft Series A $7.1M 2024-08-08 BlueYard Capital, MIT delta v, NordicNinja VC +2 11 to 50 2014
Vico Therapeutics Vico Therapeutics develops RNA modulating therapies. Biotech Leiden Series B $12.3M 2024-06-24 $115.4M Polaris Partners, Eurazeo, EQT Life Sciences +2 11 to 50 2019
MindAffect MindAffect develops brain-computer interfaces for medical applications. Artificial intelligence Nijmegen Series A $1.2M 2024-04-29 NLC, Wasteland Investments, Barco Limpo 1 to 10 2017
IridescentBio IridescentBio provides a platform that supports decision making in antibody R&D. Biotech Leiden Seed $378K 2023-12-05 $378K UNIIQ 1 to 10 2023
VivArt-X VivArt-X creates regenerating materials for women's health. Biotech Eindhoven Pre-seed $716K 2023-11-16 BOM, Brabant Startup Fund 1 to 10 2022
VectorY VectorY develops gene therapies for central nervous system, somatic, and muscle diseases. Biotech Amsterdam Series A $138.0M 2023-11-13 $175.6M Insight Partners, Benhamou Global Ventures, Forbion Capital Partners +2 51 to 100 2020
Artica Therapeutics Artica Therapeutics conducts biotechnological research and development for medical devices, pharmaceutical processes, and food. Biotech Leiden Seed $12.7M 2023-11-02 InnovationQuarter, Thuja Capital, BioGeneration Ventures +1 1 to 10 2020
Synerkine Pharma Synerkine Pharma develops fusion proteins for treating chronic pain. Biotech Utrecht Series A $5.6M 2023-10-12 InnovationQuarter, Thuja Capital, Flerie Invest +1 1 to 10 2009
Zander Labs Zander Labs builds neuroadaptive AI that learns from the brain through non-invasive EEG. Artificial intelligence Delft Seed $866K 2023-01-15 JOA Ventures 11 to 50 2016

Table 1. Biotech startups in The Netherlands: the 16 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 124.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Kynexis Kynexis develops precision medicine treatments for cognitive impairment associated with schizophrenia. Biotech Naarden Series A $112.3M 2026-08-19 $173.3M Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures 11 to 50 2023
2 Matisse Pharmaceuticals Matisse Pharmaceuticals develops therapies for sepsis and septic shock by targeting cytotoxic histones. Biotech Geleen Series A $16.0M 2026-09-17 $22.0M Brightlands Venture Partners, Chemelot Ventures, Limburg Business Development Fund (LBDF) 11 to 50 2014
3 Pan Cancer T Pan Cancer T develops T-cell receptor therapies for treating solid tumors. Biotech Rotterdam Seed $5.8M 2025-12-08 $16.3M InnovationQuarter, Thuja Capital, Van Herk Ventures +1 1 to 10 2020

Table 2. Biotech startups in The Netherlands: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Forbion Capital Partners Private equity firm Naarden, The Netherlands 3 2% 1 Kynexis
2 Thuja Capital Startup accelerator Utrecht, The Netherlands 3 2% 1 Pan Cancer T
3 InnovationQuarter Venture capital firm The Hague, The Netherlands 3 2% 1 Pan Cancer T
4 EQT Life Sciences Private equity firm Amsterdam, The Netherlands 2 2%
5 Brightlands Venture Partners Venture capital firm Geleen, The Netherlands 2 2% 1 Matisse Pharmaceuticals
6 Innovatiefonds Noord-Holland Venture capital firm Amsterdam, The Netherlands 2 2%
7 BOM Government investment office Tilburg, The Netherlands 2 2%
8 BioGeneration Ventures Micro VC fund Naarden, The Netherlands 2 2%
9 UNIIQ Government investment office The Hague, The Netherlands 2 2%
10 Kindred Capital Venture capital firm London, United Kingdom 1 1%
11 IVP Venture capital firm Menlo Park, United States 1 1%
12 Index Ventures Venture capital firm San Francisco, United States 1 1%
13 Sunstone Life Science Ventures Micro VC fund Copenhagen, Denmark 1 1% 1 Kynexis
14 Ysios Capital Venture capital firm San Sebastian, Spain 1 1% 1 Kynexis
15 Eurazeo Private equity firm Paris, France 1 1%

Table 3. Biotech startups in The Netherlands: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 80 65% $1.1B
Software 14 11% $38.1M
Artificial intelligence 7 6% $13.3M
Hardware 7 6% $7.6M
Energy 2 2%
Commerce 1 1%
Education 1 1%

Table 4. Biotech startups in The Netherlands by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 18 15% $378K
Seed 56 45% $2.0M
Series A 31 25% $8.1M
Series B 14 11% $13.8M
Series C 5 4% $13.7M

Table 5. Biotech startups in The Netherlands by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Amsterdam 23 19%
Leiden 18 15%
Utrecht 8 6%
Maastricht 8 6%
Delft 7 6%
Eindhoven 7 6%
Geleen 6 5%
Wageningen 6 5%
Rotterdam 6 5%
Groningen 5 4%
Nijmegen 4 3%
Naarden 3 2%

Table 6. Biotech startups in The Netherlands by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 8% $44.9M
September 2026 2 17% $26.0M
August 2026 1 8% $112.3M
June 2026 3 25% $34.5M
May 2026 1 8% $1.7M
March 2026 1 8% $6.4M
January 2026 1 8% $17.5M
December 2025 2 17% $31.1M

Table 7. Biotech startups in The Netherlands: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 10 8% $243.4M
2025 18 15% $345.7M
2024 15 12% $230.1M
2023 15 12% $255.8M
2022 12 10% $59.5M
2021 5 4% $100.0M

Table 8. Biotech startups in The Netherlands by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 10 8%
2020 to 2022 30 24%
2015 to 2019 46 37%
2010 to 2014 17 14%
Before 2010 20 16%

Table 9. Biotech startups in The Netherlands by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 62 52%
11 to 50 55 46%
51 to 100 2 2%
501 to 1,000 1 1%

Table 10. Biotech startups in The Netherlands by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in The Netherlands are on the list?
124, in the file dated 16 November 2026. 12 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 124 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in The Netherlands: 124 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in The Netherlands by funding stage

Other sectors in The Netherlands

Biotech startups elsewhere

Cite: FundingWatcher, 124 funded biotech companies in The Netherlands, 16 November 2026. https://fundingwatcher.com/startups/biotech/the-netherlands/